Liquet is an early stage medical device development company leveraging expertise in vascular drug delivery to transform the way cardiovascular disease is treated. We aim to commercialize novel technologies that demonstrate improved patient outcomes while thinking deeply about long term healthcare sustainability.
Liquet Medical Inc.的外部链接
US，VA，Charlottesville
It's a great time of the year to be in Boston! If you are in the neighborhood and planning to attend #RESIBOSTON, let us know, we'd love to connect!
Liquet Medical will be partnering at RESI Boston #RESIBOSTON. If you are attending, let's connect!! Send us a meeting request at https://lnkd.in/eTJr-4cP
Exciting News! ?? We are thrilled to announce that Dr. Gabriele G. Niederauer has been appointed as the new Chair of Liquet Medical's Board of Directors! Dr. Niederauer, who joined Liquet’s Board in November 2023 and has been a trusted business advisor, with deep experience in the medical device industry. Her expertise will be invaluable as we continue to advance our Versus? Catheter, a revolutionary localized drug-delivery system for treating blood clots in the lungs. "We are excited about Gabi taking on this role. She brings a wealth of experience from product development to commercialization to exit strategy," says Liquet's CEO, John Schindler. Dr. Niederauer added, "I'm truly honored to have the opportunity to serve as Liquet Medical’s Board Chair. The work that John and his exceptional team are doing to transform the way vascular disease is treated through localized drug-delivery is revolutionary." Join us in welcoming Dr. Niederauer as we embark on this exciting journey towards regulatory clearance and demonstrating our product's performance. Together, we are committed to transforming patient care and making a significant impact in the care of these patients. https://lnkd.in/eyQyAS59 #MedicalInnovation #Leadership #Healthcare #LiquetMedical #BloodClotTreatment #MedicalDevices
March is Blood Clot Awareness Month (BCAM), a time dedicated to spreading the word about blood clots and their potentially fatal complication, pulmonary embolism.?At Liquet Medical, we're dedicated to raising awareness about blood clots and their prevention. Join us this month as we share vital information and resources to help keep you informed and healthy. Together, let's #StopTheClot! ???? #ClotAwareness #LiquetMedical #HealthAwareness https://lnkd.in/e-WcVeny
Pleased to announce we are presenting at #LSIUSA24. If you are attending and interested to learn more, let us know!
?? News Alert! ?? I'm thrilled to announce that I will be attending and presenting at the upcoming #LSIUSA24 conference this March! Join me as I showcase Liquet's "Hemodynamics-Led Thrombolytic" solution for treating patients with blood clots in their lungs.?? If you're attending the conference and interested to learn more, drop me a line below. Let's connect and discuss! ?????? #MedicalInnovation #LSIUSA24 #BloodClotTreatment #meddevice
?? Grateful to have been a part of this pitch event! ?? Fellow innovators, please take note: Alamo Angels is an amazing group who made this such a relaxing, fun, and interactive experience. It was an honor for me to share our vision for transforming the way we think about and treat blood clots in the lungs. And a real pleasure to meet and stand alongside the other visionary companies, ZeroTouch and Kaleido. Wishing you all much success on your journeys. Lastly, a big thank you to #AlamoAngels for the invite and the opportunity - we are grateful! Let's continue pushing the boundaries together. #Innovation #meddevice #HealthTech #ZeroTouch #KaleidoArtMarket ??????
Last week, we hosted our first monthly pitch event of the year. We were privileged to have four companies pitch our community. ? ?? Introducing?ZeroTouch, an Ai & Automation Powered unified Endpoint Management (UEM) & Security Platform.? ?? ?? Introducing Liquet Medical Inc., creator of a new medical device aimed at revolutionizing the treatment of pulmonary embolism (PE).? ? ?? Introducing Kaleido, a new age online art market transforming art into an immersive media experience for both artists and potential customers using augmented reality.? ? Thank you to our members and guests who attended to kick-off 2024 with us.
Cheers to a year of breakthroughs, achievements, and shared accomplishments! Looking forward to celebrating many more in 2024!? We wish you a Happy New Year filled with endless possibilities and thank you for being a part of the Liquet Medical community. Warm regards, John, Derek, and the entire Team at Liquet Medical #breakthrough #happynewyear #medicaldevice
?? Thank you for celebrating our milestones with us! ?? We're thrilled to share the progress we've made in our mission to transform vascular disease treatment through localized drug delivery. ???? The Versus? Catheter and Hemodynamics-Led Thrombolysis (HLT) represent a new frontier in Catheter Directed Thrombolysis, and we're proud to lead the way. We're honored to announce that our CEO, John Schindler, will be presenting at LSI USA ‘24 in Dana Point, California, on March 18-22, 2024. ???? And for all the innovators who want to make their mark, there's still space available to present at LSI USA '24. Don't miss this opportunity to share your groundbreaking ideas. Apply today!! #Innovation #MedicalAdvancements #LSIUSA24 #HealthcareRevolution #MedTechInnovator https://lnkd.in/eDmEjw9e
Liquet Medical Inc. (#LSIUSA24 Innovator) is on a mission to transform the way vascular disease is treated through localized drug delivery. The company is developing a novel, easy-to-use, cost-effective solution to address Pulmonary blood clots. The Versus? Catheter introduces a new treatment category, Hemodynamics-Led Thrombolysis (HLT), which has the potential to become the new standard of care for Catheter Directed Thrombolysis. ?? Liquet Medical has recently achieved many recent milestones including: ? Raised $1.8M and looking to close its Seed round ? Awarded non-dilutive grants in recognition of the significance in innovation ? Completed pre-clinical in vitro data showcasing feasibility and proof-of-concept ? Currently finalizing biocompatibility and verification FDA testing Congratulations to the Liquet Medical team on their recent accomplishments! We’re excited to announce that CEO, John Schindler has been selected to present at LSI USA ‘24 in Dana Point, California on March 18-22, 2024. Interested in presenting at LSI USA ‘24? Apply to present today while space is still available. (Link in the comments)
We'd like to thank the University of Virginia Licensing & Ventures Group for hosting a wonderful afternoon of learning last week. It's truly inspiring to see how much meaningful innovation is coming out of this ecosystem! Congratulations to Dr. Nehal Mehta of Mobius Scientific and Tom Barker of Vasarya Therapeutics, and all the other amazing companies. We were honored to share the stage with you all. And a big Thank You to the team at CvilleBioHub for the opportunity to participate and share our story. What an amazing support system we have growing right here in our own backyard! https://lnkd.in/eQmwexz5
Congratulations to Dr. Nehal Mehta of Mobius Scientific, who has earned first place at the inaugural BioSpark pitch event here at LVG headquarters with CvilleBioHub! Dr. Mehta and his team have created a product to treat macular degeneration, the most common form of age-related blindness. Congrats as well to runner-up’s Tom Barker of Vasarya Therapeutics and John Schindler of Liquet Medical Inc.! #GreatAndGood #techtransfer #uvalvgseedfund Robert Creeden Nikki Hastings Charlie Henneman, CFA National Institute of Mental Health (NIMH) University of Pennsylvania School of Medicine University of Virginia